Results 231 to 240 of about 731,609 (299)
Routine immunization status of nomadic children aged five years and below in Volta Region, Ghana in the post-COVID-19 pandemic era: a cross-sectional study. [PDF]
Nambagyira A +5 more
europepmc +1 more source
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo +4 more
wiley +1 more source
Analyzing the usage of theories of change for routine immunization programs -- a review of impact evaluations from LMICs. [PDF]
Vadrevu L, Jain M, Parsekar SS.
europepmc +1 more source
IDO‐1 immunostaining identifies primary biliary cholangitis even in morphologically subtle bile duct lesions. IDO‐1 expression reflects cholangitis activity and is suppressed by ursodeoxycholic acid treatment, indicating its value as a dynamic diagnostic adjunct rather than a static marker of chronic damage.
Kaori Yoshimura +10 more
wiley +1 more source
A retrospective cohort study on predicting infants at a risk of defaulting routine immunization in Uganda using machine learning models. [PDF]
Nantongo BA +3 more
europepmc +1 more source
Abstract Background Vaccination is effective at preventing severe illness related to influenza, pneumococcal disease and coronavirus disease 2019 COVID‐19. Vaccine coverage among older Australians is incomplete, and hospitals currently administer very few vaccine doses.
Victoria Deacon +5 more
wiley +1 more source
An Upsurge of Measles Cases in Mali-a Consequence of Pandemic-associated Disruption in Routine Immunization. [PDF]
Nampota-Nkomba N +13 more
europepmc +1 more source
Abstract Complement inhibitor therapy carries a risk of serious infections, including meningococcal disease. Here we provide evidence‐based recommendations and expert consensus for immunisation and prophylactic treatment of patients receiving, or planning to receive, complement inhibitors for neurological conditions in the Australian setting.
Katherine A. Buzzard +13 more
wiley +1 more source
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley +15 more
wiley +1 more source
Correlates of Uptake of Routine Immunization amongst Under-Five Children: Comparison of Nomadic and Non-nomadic Fulani in Yobe State, Nigeria. [PDF]
Abdulhamid D +13 more
europepmc +1 more source

